Q32 Bio Inc. (QTTB) Total Non-Current Liabilities (2018 - 2026)

Q32 Bio has reported Total Non-Current Liabilities for 6 years, with the latest figure at $10.0 million in Q2 2026.

• On a quarterly basis, Total Non-Current Liabilities fell 57.34% year-over-year to $10.0 million in Q2 2026; TTM through Jun 2026 was $10.0 million, a 57.34% decrease from a year earlier, with the FY2025 full-year figure at $19.8 million, down 37.57% from the prior year.
• Total Non-Current Liabilities was $10.0 million for Q2 2026 at Q32 Bio, down from $17.4 million in the prior quarter.
• The five-year high for Total Non-Current Liabilities was $48.5 million in Q1 2024, with the low at $10.0 million in Q2 2026.
• Average Total Non-Current Liabilities over 5 years is $28.9 million, with a median of $29.7 million recorded in 2024.
• The sharpest annual moves came in 2023 and 2026: Total Non-Current Liabilities gained 13.57% in 2023, then tumbled 57.34% in 2026.
• Over 5 years, Total Non-Current Liabilities stood at $37.7 million in 2022, then gained by 13.57% to $42.8 million in 2023, then retreated by 26.1% to $31.7 million in 2024, then plunged by 37.57% to $19.8 million in 2025, then tumbled by 49.59% to $10.0 million in 2026.
• The last three Total Non-Current Liabilities figures came in at $10.0 million (Q2 2026), $17.4 million (Q1 2026), and $19.8 million (Q4 2025), per Business Quant data.